NRC HEALTH (National Research Corporation) - Q1 2000 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2000. National Research Corporation (NRC HEALTH) operates in the healthcare research and data services sector. The company is currently renovating a new headquarters building, with a planned move scheduled for July 2000.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Revenues | $4,454,823 | $3,662,923 |
| Net Income | $493,762 | $100,922 |
| Operating Income | $572,625 | $12,017 |
| Operating Margin | 12.9% | 0.3% |
| Net Cash from Operations | $808,930 | $1,318,841 |
| Cash and Equivalents (End of Period) | $330,404 | $2,164,954 |
| Working Capital | $4,021,004 | N/A |
| Debt (Current Portion) | $4,058,332 | N/A |
Note: Debt figures include the construction financing line of credit ($4,004,000) and current notes payable ($54,332).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 21.6% year-over-year, driven primarily by an expanded scope of work from existing clients and, to a lesser extent, new client acquisitions.
- Profitability Surge: Operating income jumped from $12,017 in Q1 1999 to $572,625 in Q1 2000. This was achieved despite a 56% increase in depreciation and amortization expenses.
- Expense Efficiency: Direct expenses decreased 0.4% in absolute terms and dropped significantly as a percentage of revenue (from 70.4% to 57.6%) due to reductions in software conversion costs, labor, and printing.
- Cash Flow: Net cash provided by operating activities decreased 38.6% to $809,000, attributed to the timing of receivable collections and costs incurred in advance of billings.
- Investing Activities: Net cash used in investing activities was $2.1 million, primarily for property and equipment purchases ($1.2 million) related to the new office building and net purchases of marketable securities.
Outlook, Risks, and Management Commentary
- Capital Expenditures: Management plans to spend an additional $1.8 million during the remainder of 2000 to complete the renovation of the new headquarters.
- Financing Plans: The company expects to secure long-term financing of approximately $5.8 million for the new building.
- Revenue Recognition: As of March 31, 2000, the company held $3.1 million in billings in excess of revenues earned (deferred revenue) and $874,000 in unbilled revenues. Substantially all of these amounts are expected to be earned or billed within 12 months.
- Tax Outlook: The effective tax rate for 2000 is expected to remain near the Q1 level of 31.7% due to anticipated federal tax credits.
- Stock Repurchases: Under a new authorization, 53,700 shares had been repurchased as of May 12, 2000.
- Accounting Risks: The company noted the upcoming implementation of SFAS 133 (Accounting for Derivative Instruments) but does not expect a significant impact on financial reporting.
Investor Verification Checklist
- Verify the timeline and cost overruns associated with the $1.8 million remaining renovation budget for the new headquarters.
- Confirm the status of securing the anticipated $5.8 million long-term financing for the new building.
- Monitor the conversion rate of the $3.1 million deferred revenue and $874,000 unbilled revenue into recognized income over the next 12 months.
- Assess the sustainability of the 57.6% direct expense ratio, as management expects this percentage to rise slightly for the balance of 2000.
- Review the impact of the construction financing line of credit ($4.0 million) on future liquidity and interest expense.